Ju-Seop Kang | Skin barrier function | Best Researcher Award

Posted on by Skincare

Dr. Ju-Seop Kang | Skin Barrier Function | Best Researcher Award

Professor | Hanyang University| South Korea

Dr. Ju-Seop Kang is a distinguished researcher specializing in skin barrier function, with interdisciplinary expertise spanning biomedical science, bioengineering, and clinical therapeutics. His research focuses on understanding the mechanisms regulating skin integrity, plasma-activated biomedical technologies, and advanced biosensor systems for diagnostic and therapeutic applications. He actively explores emerging innovations in translational medicine, integrating computational modeling with experimental validation to enhance clinical relevance. Dr. Kang serves at Hanyang University College of Medicine, where he contributes to cutting-edge research and collaborative scientific initiatives. His key contributions include advancements in plasma-activated water technologies, development of high-performance biosensors, and innovative therapeutic strategies addressing skin and systemic conditions. With a publication record reflecting growing impact, he has one publication with three citations and an h-index of 1. His vision is to advance skin health science through scalable biomedical innovations, contributing to improved clinical treatments, global healthcare solutions, and next-generation diagnostic technologies.

Citation Metrics (Scopus)

3000

500

100

0

Citations
2,631

Documents
94

h-index
24

🟦 Citations
🟥 Documents
🟩 h-index

View Scopus Profile View Google Scholar

Featured Publications

Meheli Ghosh | Dermatology | Research Excellence Award

Posted on by Skincare

Meheli Ghosh | Dermatology | Research Excellence Award

PHD | Mercer University | United States

Meheli Ghosh is a pharmaceutical sciences researcher specializing in advanced drug delivery systems and dermatological/transdermal formulation development. Her research focuses on topical and transdermal drug delivery, microneedle-based systems, nanoparticulate and microparticulate carriers, foam and gel formulations, and quality-by-design approaches for skin-targeted therapies, with emerging interests in regulatory-relevant bioequivalence and late-stage product development. She has gained significant research experience through collaborative projects with the U.S. Food and Drug Administration, NIH-funded programs, and industry-aligned research at Merck Group, contributing to formulation design, process optimization, IVRT/IVPT studies, and regulatory documentation. Her key contributions include the development of novel drug-loaded microneedles using vacuum compression molding, innovative nanoparticle- and emulsome-based systems for chemical injury mitigation, and advanced topical platforms addressing unmet dermatological needs. Impact Vision: Her work bridges academic research and regulatory science, accelerating the translation of safe, effective, and scalable dermatological therapies that advance global skin health and pharmaceutical innovation.

 

Citation Metrics (Google Scholar)

100

80

60

20

0

Citations
94

i10-index
4

h-index
4

🟦 Citations
🟥 i10-index
🟩 h-index


View Google Scholar

Featured Publications

 

Nida Kanwal l Micro Needling | Best Researcher Award

Posted on by Skincare

Ms. Nida Kanwal | Micro Needling | Best Researcher Award
Student | National University Of Medical Sciences | Pakistan

Ms. Nida Kanwal is a dedicated researcher currently serving as a Research Assistant in Virology at the National University of Medical Sciences (NUMS), Rawalpindi, Pakistan. She holds a Master’s degree in Microbiology and Immunology  from NUMS and a BS (Hons) in Doctor of Medical Laboratory Sciences (2016–2020) from the University of Lahore, Islamabad Campus. Her research focuses primarily on molecular virology, with expertise in RNA and DNA extraction, cDNA synthesis, qPCR, and molecular characterization of viral genes. Dr. Kanwal has contributed to several national and international conferences, including the ANSO-PAS-MAAP Conference on Pandemic Preparedness and the International Conference on Traditional Medicine. She has co-authored a publication titled “Hantavirus: an overview and advancements in therapeutic approaches for infection” in Frontiers in Microbiology  and is currently working on a study involving the identification and molecular characterization of Dengue virus NS1 and NS2 genes from recent outbreaks in Pakistan. Throughout her academic and professional journey, she has received recognition for her active participation in scientific workshops and poster presentations, including campaigns on dengue awareness and biosafety. Her interests lie in infectious disease research, emerging viral pathogens, and molecular diagnostics. Dr. Kanwal continues to expand her expertise through collaborative research and scientific contributions, aspiring to play a key role in advancing global health and virology. She has 20 citations from 3 publications with an H-index of 2.

Profiles: Scopus | ORCID

Publications

1. Afzal, S., Ali, L., Batool, A., Afzal, M., Kanwal, N., Hassan, M., Safdar, M., Ahmad, A., & Yang, J. (2023). Hantavirus: An overview and advancements in therapeutic approaches for infection. Frontiers in Microbiology.

2. Afzal, S., Ali, L., Batool, A., Kanwal, N., Hassan, M., Safdar, M., Ahmad, A., & Yang, J. (In process). Identification and molecular characterization of NS1 and NS2 genes of dengue virus from two mini outbreaks (2022–2023) in Pakistan.

3. Afzal, S. (In preparation). Molecular and structural insights into dengue virus non-structural proteins from Pakistani clinical isolates for the identification of novel antiviral targets.

.